Related references
Note: Only part of the references are listed.Understanding Causes of Hair Loss in Women
Neil Sadick et al.
DERMATOLOGIC CLINICS (2021)
Very-low-dose oral minoxidil in male androgenetic alopecia: A study with quantitative trichoscopic documentation
Rodrigo Pirmez et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
Oral Minoxidil: A Possible New Therapy for Androgenetic Alopecia
Arieh Gomolin et al.
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY (2020)
Evaluation of Hair Density and Hair Diameter in the Adult Thai Population Using Quantitative Trichoscopic Analysis
Kanchana Leerunyakul et al.
BIOMED RESEARCH INTERNATIONAL (2020)
5-Alpha reductase inhibitors in androgenetic alopecia: Shifting paradigms, current concepts, comparative efficacy, and safety
Rachita Dhurat et al.
DERMATOLOGIC THERAPY (2020)
CINeMA: An approach for assessing confidence in the results of a network meta-analysis
Adriani Nikolakopoulou et al.
PLOS MEDICINE (2020)
Efficacy and Safety of Oral Minoxidil 5 mg Once Daily in the Treatment of Male Patients with Androgenetic Alopecia: An Open-Label and Global Photographic Assessment
Ratchathorn Panchaprateep et al.
DERMATOLOGY AND THERAPY (2020)
Androgenetic alopecia in women and men: Italian guidelines adapted from European Dermatology Forum/European Academy of Dermatology and Venereology guidelines
Aurora Alessandrini et al.
GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA (2020)
Superiority of dutasteride over finasteride in hair regrowth and reversal of miniaturization in men with androgenetic alopecia: A randomized controlled open-label, evaluator-blinded study
Sujit J. S. Shanshanwal et al.
INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY (2017)
Hair regrowth in male and female pattern hair loss does not involve the conversion of vellus hair to terminal hair
D. Hugh Rushton et al.
EXPERIMENTAL DERMATOLOGY (2016)
A Single-Centre, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Investigate the Efficacy and Safety of Minoxidil Topical Foam in Frontotemporal and Vertex Androgenetic Alopecia in Men
Kathrin Hillmann et al.
SKIN PHARMACOLOGY AND PHYSIOLOGY (2015)
Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range
Xiang Wan et al.
BMC MEDICAL RESEARCH METHODOLOGY (2014)
A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia
Walter Gubelin Harcha et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2014)
被撤回的出版物: World Medical Association Declaration of Helsinki Ethical Principles for Medical Research Involving Human Subjects (Retracted article. See vol. 135, pg. 2149, 2021)
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Julian P. T. Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Efficacy, safety, and tolerability of dutasteride 0.5 mg once daily in male patients with male pattern hair loss: A randomized, double-blind, placebo-controlled, phase III study
Hee Chul Eun et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2010)
Comparing the therapeutic effects of finasteride gel and tablet in treatment of the androgenetic alopecia
Zohreh Hajheydari et al.
INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY (2009)
Minoxidil vs finasteride in the treatment of men with androgenetic alopecia
A Saraswat et al.
ARCHIVES OF DERMATOLOGY (2003)
A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men
EA Olsen et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2002)
Finasteride increases anagen hair in men with androgenetic alopecia
D Van Neste et al.
BRITISH JOURNAL OF DERMATOLOGY (2000)
Share Paper
